Literature DB >> 19397594

Progenitor cell self-renewal and cyclic neutropenia.

D Dingli1, T Antal, A Traulsen, J M Pacheco.   

Abstract

OBJECTIVES: Cyclic neutropenia (CN) is a rare genetic disorder where patients experience regular cycling of numbers of neutrophils and various other haematopoietic lineages. The nadir in neutrophil count is the main source of problems due to risk of life-threatening infections. Patients with CN benefit from granulocyte colony stimulating factor therapy, although cycling persists. Mutations in neutrophil elastase gene (ELA2) have been found in more than half of patients with CN. However, neither connection between phenotypic expression of ELA2 and CN nor the mechanism of cycling is known.
MATERIALS AND METHODS: Recently, a multicompartment model of haematopoiesis that couples stem cell replication with marrow output has been proposed. In the following, we couple this model of haematopoiesis with a linear feedback mechanism via G-CSF.
RESULTS: We propose that the phenotypic effect of ELA2 mutations leads to reduction in self-renewal of granulocytic progenitors. The body responds by overall relative increase of G-CSF and increasing progenitor cell self-renewal, leading to cell count cycling.
CONCLUSION: The model is compatible with available experimental data and makes testable predictions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397594      PMCID: PMC2695843          DOI: 10.1111/j.1365-2184.2009.00598.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  51 in total

1.  Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis.

Authors:  S Schmitz; M Loeffler; J B Jones; R D Lange; H E Wichmann
Journal:  Cell Tissue Kinet       Date:  1990-09

2.  Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.

Authors:  M Horwitz; K F Benson; R E Person; A G Aprikyan; D C Dale
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

3.  Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia.

Authors:  M Germeshausen; H Schulze; M Ballmaier; C Zeidler; K Welte
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

Review 4.  Routes to repopulation--a unification of the stochastic model and separation of stem-cell subpopulations.

Authors:  M Y Gordon; N M Blackett
Journal:  Leukemia       Date:  1994-06       Impact factor: 11.528

5.  Adult onset cyclic hematopoiesis in a patient with myelodysplastic syndrome.

Authors:  Y Abe; N Hirase; K Muta; Y Okada; T Kimura; T Umemura; J Nishimura; H Nawata
Journal:  Int J Hematol       Date:  2000-01       Impact factor: 2.490

6.  Cell kinetic status of haematopoietic stem cells.

Authors:  M C MacKey
Journal:  Cell Prolif       Date:  2001-04       Impact factor: 6.831

7.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia.

Authors:  D C Dale; M A Bonilla; M W Davis; A M Nakanishi; W P Hammond; J Kurtzberg; W Wang; A Jakubowski; E Winton; P Lalezari
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

8.  Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropenia.

Authors:  W P Hammond; G S Chatta; R G Andrews; D C Dale
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

9.  Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity.

Authors:  E J Campbell; E K Silverman; M A Campbell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

10.  Compartmental architecture and dynamics of hematopoiesis.

Authors:  David Dingli; Arne Traulsen; Jorge M Pacheco
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

View more
  8 in total

Review 1.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

2.  Oscillations in a white blood cell production model with multiple differentiation stages.

Authors:  Franziska Knauer; Thomas Stiehl; Anna Marciniak-Czochra
Journal:  J Math Biol       Date:  2019-09-26       Impact factor: 2.259

3.  On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population.

Authors:  Arne Traulsen; Tom Lenaerts; Jorge M Pacheco; David Dingli
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

4.  Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.

Authors:  Benjamin Werner; Robert E Gallagher; Elisabeth M Paietta; Mark R Litzow; Martin S Tallman; Peter H Wiernik; James L Slack; Cheryl L Willman; Zhuoxin Sun; Arne Traulsen; David Dingli
Journal:  Cancer Res       Date:  2014-07-31       Impact factor: 12.701

5.  Personalising docetaxel and G-CSF schedules in cancer patients by a clinically validated computational model.

Authors:  O Vainas; S Ariad; O Amir; W Mermershtain; V Vainstein; M Kleiman; O Inbar; R Ben-Av; A Mukherjee; S Chan; Z Agur
Journal:  Br J Cancer       Date:  2012-07-19       Impact factor: 7.640

6.  Stochastic dynamics and the evolution of mutations in stem cells.

Authors:  David Dingli; Jorge M Pacheco
Journal:  BMC Biol       Date:  2011-06-07       Impact factor: 7.431

7.  Cell lineage branching as a strategy for proliferative control.

Authors:  Gentian Buzi; Arthur D Lander; Mustafa Khammash
Journal:  BMC Biol       Date:  2015-02-19       Impact factor: 7.431

8.  A stochastic model of myeloid cell lineages in hematopoiesis and pathway mutations in acute myeloid leukemia.

Authors:  Frank Jäkel; Oliver Worm; Sascha Lange; Roland Mertelsmann
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.